Appili Therapeutics Inc.
APLIF
$0.0128
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -111.37% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -111.37% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -111.37% | |||
| SG&A Expenses | -32.89% | 115.44% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -34.03% | 13.26% | |||
| Operating Income | 34.36% | -19.82% | |||
| Income Before Tax | -594.33% | 146.69% | |||
| Income Tax Expenses | 15.54% | 371.83% | |||
| Earnings from Continuing Operations | -668.41% | 142.42% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -668.41% | 142.42% | |||
| EBIT | 34.36% | -19.82% | |||
| EBITDA | 34.43% | -19.90% | |||
| EPS Basic | -669.23% | 141.94% | |||
| Normalized Basic EPS | -600.00% | 145.00% | |||
| EPS Diluted | -669.23% | 141.94% | |||
| Normalized Diluted EPS | -600.00% | 145.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||